London, United Kingdom
ZOE, founded in 2017, is a pioneering company in the Health Care, Health and Wellness, and Nutrition sectors, headquartered in the United Kingdom. Leveraging scientific research and advanced AI technology, ZOE aims to transform how individuals approach nutrition, focusing on personalized dietary solutions that cater specifically to individual health needs.
The company's commitment to innovation is evidenced by its track record of producing influential research published in prestigious journals including Nature Medicine and The Lancet. Currently, ZOE's programs are available in the US and the UK, serving tens of thousands of users seeking to live healthier lives.
As a remote-first, well-funded scale-up, ZOE recently secured an £11.70M Series B investment on July 29, 2024, led by Coefficient Capital, underscoring investor confidence in its mission to improve global health. The company is strategically poised for growth, driven by an expert team passionate about delivering impactful results while prioritizing inclusivity and transparency.
